Document:

Exhibit 10.2

  

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

 

This Settlement
Agreement (this “Agreement”) is made as of July 31, 2018 (the “Effective Date”), by and between Eddie Galvan,
BCI Advisors, its affiliates, and assignees. (“BCI”) and MyDx, Inc. (“MyDx”). BCI and MyDx are hereinafter
referred to jointly as the “Parties” and make this Agreement in reference to the following:

 

WHEREAS,
MYDX executed an Advisory Services Agreement dated December 1, 2016 with BCI (the “Advisory” Agreement);

 

WHEREAS,
MyDx has been unable to perform on all of its obligations pursuant to the terms of this Advisory Agreement and is in default
of certain of its obligations thereunder and owes certain fees to BCI (the “Outstanding Fees”);

 

WHEREAS,
the Parties have determined that it is in the best interest to enter into this Agreement (on the terms and conditions set forth
herein) in order to further reflect their agreement and confirm the extension of the original Warrants that were issued to BCI
and subsequent issuances, and to terminate the Advisory Agreement and release each other from all rights, obligations and claims
thereunder.

 

NOW
THEREFORE, in consideration of the foregoing and the mutual representations, warranties, covenants and agreements set forth
herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending
to be legally bound hereby, agree as follows:

 

1. Termination; Settlement.
a. BCI and MyDx hereby acknowledge and agree that as of the Effective Date, (i) the Advisory Agreement is hereby terminated
in its entirety and shall be of no further force or effect, (ii) neither BCI nor MyDx shall have any further rights or obligations
under the Advisory Agreement or any of the provisions thereof.

 

b. The Parties agree that in full and final
satisfaction of any and all claims, disputes or issues that exist between them, MyDx shall, promptly, but in no event after 30
days from the Effective Date, issue, confirm and deliver to BCI: (i) an aggregate of $38,272 shares in certificate form of MyDx
Series B Preferred Stock (the “Series B Preferred Shares”) issuable to BCI Venture Partners, LLC Investments Series V,
representing the settlement of $650,000 of the entire cash Fee Outstanding and due to BCI pursuant to the December 1, 2016 Advisory
Agreement; and (ii) confirm the assignment of the A-1 and A-2 Warrants issued to BCI in January and March of 2017 attached hereto
pursuant to the Advisory Agreement to BCI Venture Partners, LLC Investment Series A-1 and Investment Series A-2, and the reissuance
of the A-2 Warrant that will include an extension of the term for an additional three (3) year period from the Expiration Date;
and; (iii) the A-3 issuable to BCI Venture Partners, LLC Investment Series A-3 pursuant to the Advisory Agreement, which warrants
shall be exercisable for a period of three (3) years from the Effective Date and A-4 warrants shall no longer be due (iv) Except
as otherwise provided herein, neither BCI nor MYDX shall be entitled to any additional services, cash, or other payment from each
other of any kind.

  

     

     

    

 

2. 
Compromise. The Parties agree and acknowledge that this Agreement is the result of a compromise and shall not be construed
as an admission by any of the Parties of any liability, wrongdoing, or responsibility on their part or on the part of their predecessors,
successors, assigns, agents, parents, subsidiaries, affiliates, officers, directors, advisors, sub-contractors, employees or assignees.
Indeed, the Parties expressly deny any such liability, wrongdoing or responsibility.

 

3.  Payment
in Full. The provisions agreed to the parties as set forth in Section 1 shall be in full and final satisfaction of any
amounts claimed or owed by either of the parties.

 

4.  Releases.
Release by MYDX. Except as to those obligations created by this Agreement, MYDX does hereby fully and forever release,
acquit and discharge BCI along with BCI’s, attorneys, officers, principals, directors, shareholders, joint and co-venturers, employees,
subcontractors, advisors, insurers, agents, administrators, executors, heirs, consultants, BCI primary point of contact also referred
to as the PPC, assigns and representatives of every nature, from any and all accounts, allegations, claims, costs, debts, demands,
expenses, injuries, liabilities, liens, losses or damages, obligations, rights, actions at law in equity or otherwise, and causes
of action whatsoever including any third Party right to indemnity or contribution in reference to any claim related (whether directly
or indirectly) to the action, known or unknown, suspected or unsuspected, and those that exist as well as those that may come into
existence in the future against BCI. This release shall be construed as broadly as possible in favor of BCI. As to such matters
being released, MYDX expressly waives and relinquishes any right or benefit, which he has or may have under the provisions of Section
1542 of the Civil Code of the State of California or under any similar statute or principle of common law, which provides as follows:
“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE
TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”
MYDX and BCI, and each of them, hereby expressly, understand and acknowledge the significance and consequences of the foregoing
specific waiver of said Section 1542. The Parties, and each of them, intentionally waive the provisions of Section 1542 upon the
advice of his; her or its legal counsel, and each Party accepts full responsibility for any injury, damage or loss which may hereafter
arise in respect of such releases, although unknown or unanticipated at the time of execution of this Agreement.

  

    	 	1	 

     

    

 

5.  Release
by BCI. Except as to those obligations created by this Agreement, BCI does hereby fully and forever release, acquit
and discharge MYDX along with MYDX’s, attorneys, officers, principals, directors, shareholders, joint and
co-venturers, employees, subcontractors, advisors, insurers, agents, administrators, executors, heirs, assigns and
representatives of every nature, from any and all accounts, allegations, claims, costs, debts, demands, expenses, injuries,
liabilities, liens, losses or damages, obligations, rights, actions at law in equity or otherwise, and causes of action
whatsoever including any third party right to indemnity or contribution in reference to any claim related (whether directly
or indirectly) to the Action, known or unknown, suspected or unsuspected, and those that exist as well as those that may come
into existence in the future against MYDX. This release shall be construed as broadly as possible in favor of MYDX. As to
such matters being released, BCI expressly waive and relinquish any right or benefit, which they have or may have under the
provisions of Section 1542 of the Civil Code of the State of California or under any similar statute or principle of common
law, which provides as follows: “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT
TO EXIST 1N HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED
HIS OR HER SETTLEMENT WITH THE DEBTOR.” BCI and MYDX, and each of them, hereby expressly, understand and acknowledge the
significance and consequences of the foregoing specific waiver of said Section 1542. The Parties, and each of them,
intentionally waive the provisions of Section 1542 upon the advice of his, her or its legal counsel, and each Party accepts
full responsibility for any injury, damage or loss which may hereafter arise in respect of such releases, although unknown or
unanticipated at the time of execution of this Agreement.

 

6.    Reserve Shares
of MyDx.

In connection with this
Agreement, MyDx shall execute and deliver to BCI an Irrevocable Transfer Agent instruction letter pursuant to which it directs
its transfer agent to reserve the number of shares required under each of the Warrants and Series B Preferred Stock issuable pursuant
to Section 1 of this Agreement.

 

7.    Non-Disparagement.

Each Party agrees not to disparage
the other, or otherwise take any action which could reasonably be expected to adversely affect the other Party’s personal or professional
reputation.

 

8.    Covenant
Not to Sue. (a) Each of the Parties hereby absolutely, unconditionally and irrevocably covenant and agree with and in favor
of each other that they will not sue or bring any action or proceeding (at law, in equity, in any regulatory, mediation or arbitration
proceeding or otherwise) against any the other on the basis of any of the matters released hereby. (b) Each of the Parties hereby
agrees that this Agreement and the covenant not to sue set forth herein may be pleaded as a full and complete defense and may be
used as a basis for an injunction against any action, suit or other proceeding that may be instituted, prosecuted or attempted
in breach of the provisions of this Agreement. Each of the Parties hereby agrees that no fact, event, circumstance, evidence or
transaction that could now be asserted or that may hereafter be discovered shall affect in any manner the final, absolute and unconditional
nature of this Agreement and the covenant not to sue set forth herein.

 

9.    Miscellaneous
Terms and Conditions. a. Following execution of this Agreement, the Parties shall as soon as practicable take the actions
and prepare any and all appropriate documents reasonably necessary to effectuate this Agreement.

 

b. Each Party shall bear its
own attorneys’ fees and costs.c. This Agreement may be modified only by a written document signed by the Parties. No waiver of
this Agreement or of any of the promises, obligations, terms, or conditions hereof shall be valid unless it is written and signed
by the Party against whom the waiver is to be enforced.

  

    	 	2	 

     

    

 

d.  This Agreement shall be binding
upon and shall inure to the benefit of the Parties thereto, their predecessors, successors, parents, subsidiaries, affiliates,
assigns, agents, directors, officers, employees, advisors, sub-contractors and shareholders.

 

e.  If any part or any provision
of this Agreement shall be finally determined to be invalid or unenforceable under applicable law, that part shall be ineffective
to the extent of such invalidity or unenforceability only, without in any way affecting the remaining parts of said provision or
the remaining provisions of said Agreement. Furthermore, the Parties agree that in the event of an illegal, invalid or unenforceable
provision, the Parties shall use their best efforts to induce the reviewing court to substitute a legally enforceable provision
effectuating the intent of the Parties (as can be discerned from the subject provision and the rest of the Agreement) as closely
as possible, and, should the court be unwilling to perform such substitution, to use their best efforts to do so between themselves
and to add such new provision to this Agreement.

 

f.   This Agreement
shall be governed by and construed in accordance with laws of New York, without regard to its choice of law rules. The state or
federal courts situated in Manhattan shall retain exclusive jurisdiction over any and all disputes arising out of or otherwise
relating to the subject matter of this Agreement.

 

g.  Each Party acknowledges
that it has read the document thoroughly and completely, has had the opportunity to consult legal counsel of its choosing, understands
the rights, remedies and allegations surrounding the execution of this document, and that the document is executed voluntarily.

 

h.  Each person who executes
this Agreement by or on behalf of each -5- respective Party warrants and represents that he or she has been duly authorized
and empowered to execute and deliver this Agreement on behalf of such Party.

 

i.   The Parties cooperated
in the drafting of this Agreement, and in the event that it is determined that any provision herein is ambiguous, that provision
shall not be presumptively construed against either Party.

 

j.   In the event that either
Party breaches any term of this Agreement and the other Party is required to employ counsel to enforce its rights, the prevailing
Party shall be entitled to recover its attorneys’ fees and costs incurred therein.

 

k.  This Agreement contains the
complete agreement between the Parties with respect to its subject matter and supersedes any and all prior agreements, understanding,
promises, warranties, and representations made by each Party to the other concerning the subject matter.

 

1. The Parties hereby warrant
and represent that they have not assigned or in any way transferred or conveyed all or any portion of the claims covered by
this Agreement, and to their knowledge, no other person or entity has a right to any claim that purports to be settled by
this Agreement. The Parties acknowledge and agree that this warranty and representation is an essential and material term of
this Agreement, without which they would not have entered into it. The Parties each agree to defend and to hold each other
harmless against the claims of any other person or entity asserting a claim or right that purports to be settled by the
Agreement.

 

10. Counterparts /
Facsimile Signatures. This Agreement may be executed in counterparts, and each counterpart, when executed, shall have the
efficacy of a signed original. This Agreement may be executed by facsimile signatures which shall be deemed to have the same force
and effect as an original signature.

  

    	 	3	 

     

    

 

WHEREFORE, having fully read
and understood the terms of this Agreement, the Parties sign their names below with the intention that they shall be bound by it.

 

	MYDX, INC.	 
	 	 
	By:	/s/ Daniel Yazbeck	 
	Daniel Yazbeck, CEO	 
	 	 
	Eddie Galvan- BCI Advisors	 
	 	 
	By:	/s/
Eddie Galvan	 
	Eddie Galvan, an individual	 
	 	 
	BCI Advisors, LLC	 
	 	 
	Name:	/s/
Eddie Galvan	 
	Eddie Galvan, Managing Member	 
	 	 
	Name:	/s/
Eddie Galvan	 
	BCI Advisor, LLC Investment Series 2	 
	Eddie Galvan, Managing Member	 
	 	 
	Name:	/s/ Eddie Galvan	 
	BCI Advisor Investment Series 3	 
	Eddie Galvan, Managing Member	 

  

    	 	4Exhibit 10.3

 

COMMON
STOCK PURCHASE WARRANT

A-1

 

VOID
AFTER 5:00 P.M., EASTERN TIME ON January 15, 2019 

 

For
the Purchase of Seven and One-Half Percent (7.5%) of the 

Issued
and Outstanding Shares of Common Stock, $0.001 Value

of

MyDx,
Inc.

a
Nevada corporation

 

THIS
CERTIFIES THAT, for value received, BCI Venture Partners, LLC Investment Series A-1 (the “Holder”), as registered
owner of this Common Stock Purchase Warrant (“Warrant”), is entitled to, at any time at or before the Expiration Date
(as defined below), but not thereafter, to subscribe for, purchase and receive seven and one half percent (7.5%) of the common
shares issued and outstanding at the time of exercise, of the fully paid and non assessable shares of common stock (the “Common
Stock”), of MyDx, Inc., a Nevada corporation (the “Company”), at $.001 per share (the “Exercise Price”),
upon presentation and surrender of this Warrant and upon payment by cashier’s check, wire transfer or credit of the Exercise
Price for such Common Stock to the Company at the principal office of the Company; provided, however, that upon the occurrence
of any of the events specified in the Statement of Rights of Warrant Holder, a copy of which is attached as Annex 1 hereto, and
by this reference made a part hereof, the rights granted by this Warrant shall be adjusted as therein specified.

 

Upon
exercise of this Warrant, the form of election must be duly executed and the instructions for registration of the Shares acquired
by such exercise must be completed.

 

The
term Expiration Date (the “Expiration Date”) means the earliest of (i) the second anniversary of the date hereof,
(ii) immediately prior to the sale of all of substantially all of the Company’s assets, or (iii) immediately prior to a
merger or consolidation in which securities possessing more than 50% of the total combined voting power of the Company’s
outstanding securities are transferred to a person or persons different from the persons holding those securities immediately
prior to such transaction; provided, that the Company shall give notice to the Holder at least 10 days prior to the events set
forth in clauses (i), (ii) and (iii) above.

 

If
the subscription rights represented hereby are not exercised at or before the Expiration Date, this Warrant shall become void,
and all rights represented hereby shall cease and expire.

 

This
Warrant may be exercised in accordance with its terms in whole or in part. In the event of the exercise or assignment hereof in
part only, the Company shall cause to be delivered to the Holder a new Warrant of like tenor to this Warrant in the name of the
Holder, evidencing the right of the Holder to purchase the number of Shares purchasable hereunder as to which this Warrant has
not been exercised or assigned.

 

In
no event shall this Warrant (or the Shares issuable, upon full or partial exercise hereof) be offered or sold except in conformity
with the Securities Act of 1933; as amended.

 

    

     

    

 

COMMON
STOCK PURCHASE WARRANT A-1

SIGNATURE
PAGE 

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer this January 15, 2017.

 

	 	MyDx, Inc.
	 	 	 
	 	By:	 
	 	 	Daniel Yazbeck
	 	 	Chief Executive Officer

 

    	 	2	 

     

    

 

Form
to be used to exercise Warrant:

 

	TO: MyDx,
Inc	DATE:_______________

 

The
Undersigned ________________________pursuant to the provisions of the within Warrant, hereby elects to purchase MyDx, Inc. Warrants
covered by the within Warrant.

 

__________________________

(Name)

 

__________________________

(Address)

 

__________________________

By:
Eddie Galvan

Its:
Manager BCI Venture Partners, LLC

By:

 

and
if said number of Warrants exercised shall not be all the Warrants evidenced by the within Warrant Certificate, issue a new Warrant
Certificate for the remaining balance of Warrants to the undersigned at the address below.

 

	Name of Holder:	 	 
	 	(Please Print)	 
	 	 	 
	Signature:	 	 
	 	 	 
	 	 	 
	 	(Address)	 

 

NOTICE:
      The signature to exercise must correspond with the name upon the face of the Warrant in every particular without
alteration or enlargement or any change whatsoever.

 

    	 	3	 

     

    

 

Form
to be used to transfer Warrants:

 

	TO:	MyDx,
                                         Inc.
	 	 
	DATE:	__________________________

 

FOR
VALUE RECEIVED, _____________________________hereby irrevocably sells, assigns and transfers unto ______________________________
the attached Warrant, together with all right, title and interest therein, and does hereby irrevocably constitute and appoint
the Manager or the Secretary of the Company attorney, to transfer said Warrant Certificate on the books of the company with the
full power of substitution in the premises.

 

Name
of Holder:

 

	Signature:	 	 
	 	 	 
	 	 	 
	 	(Address)	 

 

Form
to be used for partial assignment of Warrants:

 

 

FOR
VALUE RECEIVED, _________________ hereby sells, assigns and transfers unto __________________ the right to purchase _________
shares of Warrant Stock evidenced by the within Warrant together with all right, title and interest therein, and does hereby irrevocably
constitute and appoint the Secretary of the Company attorney, to transfer said Warrant Certificate on the books of the company
with the full power of substitution in the premises.

 

	Name of Holder:	 	 
	 	(Please Print)	 
	 	 	 
	Signature:	 	 
	 	 	 
	 	 	 
	 	(Address)	 

 

    	 	4	 

     

    

 

ANNEX
1 TO MyDx, INC.

COMMON
STOCK PURCHASE WARRANT A-1

 

STATEMENT
OF RIGHTS OF WARRANT HOLDER

 

1. Exercise
of Warrant. This Warrant may be exercised in whole or in part at any time at or before the Expiration Date (as defined in
the Warrant), by presentation and surrender hereof to the Company, with the Exercise Form annexed hereto duly executed and accompanied
by payment to the Company of an amount of consideration therefor equal to the Warrant Price in effect on the date of such exercise
multiplied by the number of shares of Warrant Stock with respect to which this Warrant is then being exercised, payable at such
Holder's election by wire transfer to an account designated by the Company, by cashless exercise in accordance with the provisions
of Section 3.4, but only when a registration statement under the Securities Act providing for the resale of the Warrant Stock
is not then in effect, or by a combination of the foregoing methods of payment selected by the Holder of this Warrant. If this
Warrant should be exercised in part only, the Company shall, upon surrender of this Warrant for cancellation, execute and deliver
a new Warrant evidencing the right of the Holder to purchase the balance of the shares purchasable hereunder. Upon receipt by
the Company of this Warrant and the Exercise Price at the office or agency of the Company, in proper form for exercise, the Holder
shall be deemed to be the holder of record of the common stock issuable upon such exercise, notwithstanding that the stock transfer
books of the Company shall then be closed or that certificates representing such common stock shall not then be actually delivered
to the Holder.

 

2. Rights
of the Holder. The Holder shall not, by virtue hereof, be entitled to any rights of a member in the Company, either at law
or equity, and the rights of the Holder are limited to those expressed in the Warrant and are not enforceable against the Company
except to the extent set forth herein.

 

3. Adjustment
in Number of Shares and Certain Exercise Restrictions.

 

(A) Adjustment
for Reclassifications. In case at any time or from time to time after January 15, 2017 (“Issue Date”) the holders
of the Common Stock of the Company (or any shares or other securities at the time receivable upon the exercise of this Warrant)
shall have received, or, on or after the record date fixed for the determination of eligible members, shall have become entitled
to receive, without payment therefore, other or additional shares or other securities or property (other than cash) by way of
share-split, spinoff, reclassification, combination of shares or similar corporate rearrangement (exclusive of any dividend of
its or any subsidiary’s shares), then and in each such case, the Holder of this Warrant, upon the exercise hereof as provided
in Section 1, shall be entitled to receive the amount of securities and property which such Holder would hold on the date of such
exercise if on the Issue Date he had been the holder of record of the number of common stock shares of the Company called for
on the face of this Warrant and had thereafter, during the period from the Issue Date, to and including the date of such exercise,
retained such shares and/or all other or additional securities and property receivable by him as aforesaid during such period,
giving effect to all adjustments called for during such period.

 

    	 	5	 

     

    

 

(B) 
Adjustment for Reorganization, Consolidation, Merger. In case of any reorganization of the Company (or any other company
the securities of which are at the time receivable on the exercise of this Warrant) after the Issue Date, or in case, after such
date, the Company (or any such other company) shall consolidate with or merge into another company or convey all, or substantially
all, of its assets to another company, then and in each such case the Holder of this Warrant, upon the exercise hereof as provided
in Section 1 at any time after the consummation of such reorganization, consolidation, merger or conveyance, shall be entitled
to receive, in lieu of the securities and property receivable upon the exercise of this Warrant prior to such consummation, the
securities or property to which such Holder would be entitled had the Holder exercised this Warrant immediately prior thereto,
all subject to further adjustment as provided herein; in each such case, the terms of this Warrant shall be applicable to the
shares or other securities or property receivable upon the exercise of this Warrant after such consummation.

 

(C) 
Exercise Restrictions. Notwithstanding anything to the contrary set forth in this Warrant, at no time may a Holder of this
Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when
aggregated with all other shares of Common Stock owned by such Holder at such time, the number of shares of Common Stock which
would result in such Holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules
thereunder) in excess of 4.99% of the then issued and outstanding shares of Common Stock; provided, however, that upon a holder
of this Warrant providing the Company with sixty-one (61) days notice that such Holder would like to waive this Section 3(C) with
regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 3(C) will be of no force or effect
with regard to all or a portion of the Warrant referenced in the a waiver notice; provided, further, that this provision shall
be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

 

3.4 Cashless
Exercise. Notwithstanding any provisions herein to the contrary and commencing one year following the original issue date
if the per share market value of one share of Common Stock is greater than the Exercise Price and a registration statement under
the Securities Act providing for the resale of the Warrant Stock is not then in effect by the date such registration statement
is required or not effective at any time during the effectiveness period, in lieu of exercising this Warrant by payment of cash,
the Holder may exercise this Warrant by a cashless exercise and shall receive the number of shares of Common Stock equal to an
amount by surrender of this Warrant at the principal office of the Company together with the properly endorsed Notice of Exercise
in which event the Company shall issue to the Holder a number of shares of Common Stock that create is computed.

 

3.5 Adjustment
in Exercise Price. Under no circumstances shall the Exercise Price of the Warrant change. Therefore, in the case of a reverse
stock split or recapitalization or any other event, subsequent to any such event, the Exercise Price shall remain $.001.

 

4. Notices
to Warrant Holders. So long as this Warrant shall be outstanding and unexercised if the Company shall take any action which
would trigger an adjustment (as set forth in Section 3), then, in any such case, the Company shall cause to be delivered to the
Holder, at least ten days prior to the date specified in (x) or (y) below, as the case may be, notice containing a brief description
of the proposed action and stating the date on which (x) a record is to be taken for the purpose of such dividend, distribution
or rights, or (y) such reclassification, reorganization, consolidation, merger, conveyance; lease, dissolution, liquidation or
winding up is to take place and the date, if any, is to be fixed, as of which the holders of Common Stock of record shall be entitled
to exchange their common stock for securities or other property deliverable upon such reclassification, reorganization, consolidation,
merger, conveyance, dissolution, liquidation or winding up.

 

    	 	6	 

     

    

 

5. Officer’s
Certificate. Whenever the number of common stock issuable upon exercise of this Warrant or the Exercise Price shall be adjusted
as required by the provisions hereof, the Company shall forthwith file in the custody of its Secretary or an Assistant Secretary
at its principal office, and with its stock transfer agent, if any, an officer’s certificate showing the adjusted number
of common stock or Exercise Price determined as herein provided and setting forth in reasonable detail the facts requiring such
adjustment. Each such officer’s certificate shall be made available at all reasonable times for inspection by the Holder
and the Company shall, forthwith after each such adjustment, deliver a copy of such certificate to the Holder. Such certificate
shall be conclusive as to the correctness of such adjustment.

 

6. Restrictions
on Transfer. The Holder of this Warrant, by acceptance thereof; agrees that, absent an effective registration statement, under
the Securities Act of 1933 (the “Act”), covering the disposition of this Warrant or the Common Stock issued or issuable
upon exercise hereof, such Holder will not sell or transfer any or all of this Warrant or such Common Stock without first providing
the Company with an opinion of counsel reasonably satisfactory to the Company to the effect that such sale or transfer will be
exempt from the registration and prospectus delivery requirements of the Act. The certificates evidencing the Warrant and Common
Stock which will be delivered to such Holder by the Company shall bear substantially the following legend:

 

THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN
ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REQUIREMENTS FOR SUCH REGISTRATION FOR NONPUBLIC OFFERINGS. ACCORDINGLY, THE SALE,
TRANSFER. PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES EVIDENCED HEREBY OR ANY PORTION THEREOF OR INTEREST THEREIN
MAY NOT BE ACCOMPLISHED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THAT ACT OR AN OPINION OF COUNSEL TO THE HOLDER
OF THE SECURITIES (UNLESS THE COMPANY DETERMINES IN ITS SOLE DISCRETION TO USE ITS OWN COUNSEL), WITH ANY SUCH COUNSEL AND OPINION
OF COUNSEL TO BE REASONABLY ACCEPTABLE TO THE ISSUER, TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED.

 

Each
Holder of this Warrant, at the time all or a portion of such Warrant is exercised, agrees to make such written representations
to the Company as counsel for the Company may reasonably request, in order that the Company may be reasonably satisfied that such
exercise of the Warrant and consequent issuance of Common Stock will not violate the registration and prospectus delivery requirements
of the Act, or other applicable state securities laws.

 

    	 	7	 

     

    

 

7.
 Piggyback Registration Rights. If, at any time after the Issue Date and expiring
on the Expiration Date, the Company proposes to register any of its securities under the Act either for its own account or for
the account of others, in connection with the public offering of such equity securities solely for cash, on a registration form
that would also permit the registration of the common stock issuable upon exercise of this Warrant (“Warrant Shares”),
the Company shall promptly give the Holder written notice of such proposal. Within thirty (30) days after the notice is given,
the Holder shall give notice as to the number of Warrant Shares, if any, which have vested and which the Holder requests be registered
simultaneously with such registration by the Company. The Company shall use its best efforts to include such Warrant Shares in
such registration statement (or in a separate registration statement concurrently filed) which the Holder requests to be so included
and to cause such registration statement to become effective with respect to such shares in accordance with the registration procedures
set forth in Section 8 hereof. If at any time after giving written notice of its intention to register equity securities and before
the effectiveness of the registration statement filed in connection with such registration, the Company determines for any reason
either not to effect such registration or to delay such registration, the Company may, at its election, by delivery of written
notice to the Holder, (i) in the case of a determination not to effect registration, relieve itself of a reasonably necessary
portion of its obligation to register the Warrant Shares under this Section 7 in connection with such registration, or (ii) in
the case of a determination to delay registration, delay the registration of the Warrant Shares under this Section 7 for the same
period as the delay in the registration of such other equity securities. Each Holder of Warrant Shares requesting inclusion in
a registration pursuant to this Section 7 may, at any time before the effective date of the registration statement relating to
such registration, revoke such request by delivering written notice of such revocation to the Company (which notice shall be effective
only upon receipt by the Company); provided, however, that if the Company, in consultation with its financial and legal
advisors, determines that such revocation would require a recirculation of the prospectus contained in the registration statement,
then such Holder of Warrant Shares shall have no right to revoke its request.

 

8.
 Expenses and Procedures.

 

(A) Expenses
of Registration. All registration expenses (exclusive of underwriting discounts and commissions) shall be borne by the Company;
provided, however, that if a Holder revokes a registration request pursuant to the last sentence of Section 7, the registration
expenses in connection with such revoked registration shall be borne by such Holder. Each Holder of Warrant Shares shall bear
all underwriting discounts, selling commissions, sales concessions and similar expenses applicable to the sale of the Warrant
Shares sold by such Holder.

 

(B) Registration
Procedures. In the case of the registration, qualification or compliance effected by the Company pursuant to Section 7 hereof,
the Company will keep the Holders of Warrant Shares advised as to the initiation of registration, qualification and compliance
and as to the completion thereof. At its expense, the Company will furnish such number of prospectuses and other documents incident
thereto as the Holders or underwriters from time to time may reasonably request.

 

(C) Information.
The Company may require each seller of Warrant Shares as to which any registration is being effected to furnish such information
regarding the distribution of such Warrant Shares as the Company may from time to time reasonably request and the Company may
exclude from such registration the Warrant Shares of any seller who unreasonably fails to furnish such information after receiving
such request.

 

(D) Blue
Sky. The Company will, as expeditiously as possible, use its best efforts to register or qualify the Warrant Shares covered
by a registration statement at the expense of the Company in such jurisdictions as the holders of such Warrant Shares or, in the
case of an underwritten public offering, the managing underwriter shall reasonably request at the expense of the Holders of the
Warrant Shares being registered provided that the Company shall not be required in connection with any such registration or qualification
or as a condition thereto to qualify to do business in any jurisdiction where it is not so qualified or to take any action which
would subject it to taxation or service of process in any jurisdiction where it is not otherwise subject to such taxation or service
of process.

 

    	 	8	 

     

    

 

(E) Notification
of Material Events. The Company will, as expeditiously as possible, immediately notify each holder of Warrant Shares under
a registration statement, at any time when a prospectus relating thereto is required to be delivered under the Act, of the happening
of any event as a result of which the prospectus contained in such registration statement, as then in effect, includes an untrue
statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing and, as expeditiously as possible, amend or supplement
such prospectus to eliminate the untrue statement or the omission.

 

9. Indemnification.

 

(A) Indemnification
by Company. The Company shall, without limitation as to time, indemnify and hold harmless, to the full extent permitted by
law, each holder of Warrant Shares, its officers, directors, agents and employees, each person who controls such holder (within
the meaning of Section 15 of the Act or Section 20 of the Securities Exchange Act of 1934, as amended, hereinafter the “Exchange
Act”), and the officers, directors, agents or employees of any such controlling person, from and against all losses, claims,
damages, liabilities, costs (including, without limitation, all reasonable attorneys’ fees) and expenses (collectively “Loss”
or “Losses”), as incurred, arising out of or based upon any untrue statement or alleged untrue statement of a material
fact contained in any registration statement, prospectus or preliminary prospectus or any amendment or supplement thereto, or
arising out of or based upon any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein in light of the circumstances under which they were made (in the case of any prospectus) not misleading,
except insofar as the same are based solely upon information furnished to the Company by such holder for use therein; provided,
however, that the Company shall not be liable in any such case to the extent that any such Loss arises out of or is based upon
an untrue statement or alleged untrue statement or omission made in any preliminary prospectus or prospectus if (i) such holder
failed to send or deliver a copy of the prospectus or prospectus supplement with or prior to the delivery of written confirmation
of the sale of Warrant Shares and (ii) the prospectus or prospectus supplement would have corrected such untrue statement or omission.
If requested, the Company shall also indemnify underwriters, selling brokers, dealer managers and similar securities industry
professionals participating in the distribution, their officers, directors, agents and employees and each person who controls
such persons (within the meaning of Section 15 of the Act or Section 20 of the Exchange Act) to the same extent as provided above
with respect to the indemnification of the Holders of Warrant Shares. It is agreed that the indemnity agreement contained in this
Section 9(A) shall not apply to amounts paid in settlement of any such Loss if such settlement is effected without the consent
of the Company (which consent has not been unreasonably withheld).

 

    	 	9	 

     

    

 

(B) Conduct
of Indemnification Proceedings. If any action or proceeding (including any governmental investigation or inquiry) shall be
brought or any claim shall be asserted against any person entitled to indemnity hereunder (an “Indemnified Party”),
such indemnified party shall promptly notify the party from which such indemnity is sought (the “Indemnifying Party”)
in writing, and the indemnifying party shall assume the defense thereof including the employment of counsel reasonably satisfactory
to the indemnified party and the payment of all fees and expenses incurred in connection with the defense thereof. All such fees
and expenses (including any fees and expenses incurred in connection with investigation or preparing to defend such action or
proceeding) shall be paid to the indemnified party, as incurred, within 20 days of written notice thereof to the indemnifying
party; provided, however, that if, in accordance with this Section 9, the indemnifying party is not liable to the indemnified
party, such fees and expenses shall be returned promptly to the indemnifying party. Any such indemnified party shall have the
right to employ separate counsel in any such action, claim or proceeding and to participate in the defense thereof, but the fees
and expenses of such counsel shall be the expense of such indemnified party unless (a) the indemnifying party has agreed to pay
such fees and expenses, (b) the indemnifying party shall have failed promptly to assume the defense of such action, claim or proceeding
and to employ counsel reasonably satisfactory to the indemnified party in any such action, claim or proceeding, or (c) the named
parties to any such action, claim or proceeding (including any impleaded parties) include both such indemnified party and the
indemnifying party, and such indemnified party shall have been advised by counsel that there may be one or more legal defenses
available to it which are different from or additional to those available to the indemnifying party (in which case, if such indemnified
party notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying
party, the indemnifying party shall not have the right to assume the defense of such action, claim or proceeding on behalf of
such indemnified party, it being understood, however, that the indemnifying party shall not, in connection with any one such action,
claim or proceeding or separate but substantially similar or related actions, claims or proceedings in the same jurisdiction arising
out of the same general allegations or circumstances, be liable for the reasonable fees and expenses of more than one separate
firm of attorneys (together with appropriate local counsel) at any time for all such indemnified parties, unless in the opinion
of counsel for such indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified
parties with respect to such action, claim or proceeding, in which event the indemnifying party shall be obligated to pay the
fees and expenses of such additional counsel or counsels). No indemnifying party will consent to entry of any judgment or enter
into any settlement which does not include as an unconditional term thereof the release of such indemnified party from all liability
in respect to such claim or litigation without the written consent (which consent will not be unreasonably withheld) of the indemnified
party. No indemnified party shall consent to entry of any judgment or enter into any settlement without the written consent (which
consent will not be unreasonably withheld) of the indemnifying party from which indemnify or contribution is sought.

 

(C) Contribution.
If the indemnification provided for in this Section 9 is unavailable to an indemnified party under Section 9(A) or 9(B) hereof
(other than by reason of exceptions provided in those Sections) in respect of any Losses, then each applicable indemnifying party
in lieu of indemnifying such indemnified party shall contribute to the amount paid or payable by such indemnified party as a result
of such Losses, in such proportion as is appropriate to reflect the relative fault of the indemnifying party and indemnified party
in connection with the actions, statements or omissions which resulted in such Losses as well as any other relevant equitable
considerations. The relative fault of such indemnifying party and the indemnified party shall be determined by reference to, among
other things, whether any action in question, including any untrue statement or alleged untrue statement of a material fact or
omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by such indemnifying
party or indemnified party, and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed
to include, subject to the limitations set forth in Section 9(B), any legal or other fees or expenses reasonably incurred by such
party in connection with any action, suit, claim, investigation or proceeding. The parties hereto agree that it would not be just
and equitable if contribution pursuant to this Section 9(C) were determined by pro rata allocation or by any other method of allocation
which does not take into account the equitable considerations referred to in the immediately preceding paragraph. No person guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation.

 

    	 	10	 

     

    

 

10. Loss
or Mutilation. Upon receipt by the Company of evidence satisfactory to it (in the exercise of reasonable discretion) of the
ownership of and the loss, theft, destruction or mutilation of any Warrant and (in the case of loss, theft or destruction) of
indemnity satisfactory to it (in the exercise of reasonable discretion), and (in the case of mutilation) upon surrender and cancellation
thereof, the Company will execute and deliver in lieu thereof a new Warrant of like tenor.

 

11. Reservation
of Shares. The Company shall at all times reserve and keep available for issue upon the exercise of Warrants such number of
its authorized but unissued common stock as will be sufficient to permit the exercise in full of all outstanding Warrants.

 

12. Notices.
All notices and other communications from the Company to the Holder of this Warrant shall be mailed by first class registered
or certified mail, postage prepaid, to the address furnished to the Company in writing by the last Holder of this Warrant who
shall have furnished an address to the Company in writing.

 

13. Change;
Waiver. Neither this Warrant nor any term hereof may be changed, waived, discharged or terminated orally but only by an instrument
in writing signed by the party against which enforcement of the change, waiver, discharge or termination is sought.

 

14. Law
Governing. This Warrant shall be construed and enforced in accordance with and governed by the laws of the State of Nevada.

 

DATED:          January
15, 2017

 

	 	MyDx, Inc.
	 	A Nevada corporation
	 	 
	 	By:	 
	 	 	Daniel Yazbeck
	 	 	Chief Executive Officer

 

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]